Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers

Critical Reviews in Clinical Laboratory Sciences

Volumn 46, Issue 5-6, 2009, Pages 241-281

  Giustarini, Daniela ^a   Dalle Donne, Isabella ^b   Tsikas, Dimitrios ^c   Rossi, Ranieri ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anti oxidants; Bioanalytical validation; Biomarker(s) of oxidative stress; Clinical trials; Free radicals; Human diseases; Nitrosative stress; Oxidative damage; Oxidative stress; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; ALLANTOIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BILIRUBIN; BIOLOGICAL MARKER; CAROTENOID; FLAVONOID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; ISOPROSTANE; LIPID HYDROPEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE; POLYPHENOL; POLYUNSATURATED FATTY ACID; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ANALYTIC METHOD; ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CATARACT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL CHEMISTRY; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIUM INJURY; HEAD AND NECK CANCER; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; ISCHEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MEDICATION ERROR; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SCIENTIFIC MISCONDUCT; SENSITIVITY AND SPECIFICITY; STROKE; VASCULAR DISEASE;

ANIMALS; BIOLOGICAL MARKERS; DISEASE; HUMANS; OXIDATIVE STRESS;

EID: 71849114694     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408360903142326     Document Type: Review

References (299)

1. Sies H. Oxidative stress. Introductory remarks. In: Sies H, Ed. Oxidative Stress. Pp 1-8. London: Academic Press, 1985.
2. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.
3. Halliwell B, Gutteridge JMC. Antioxidant defences. In: Halliwell B, Gutteridge JMC, Eds. Free Radicals in Biology and Medicine, 3rd Ed. Pp 105-245. Oxford: Clarendon Press, 1999.
4. Klotz LO, Kroncke KD, Buchczyk DP, Sies H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr 2003; 133(5 Suppl): 1448S-1451S.
5. Sies H. In Sies H, Ed. Oxidative Stress: Introduction. pp xv-xxii. London: Academic Press, 1991.
6. Dalle-Donne I, Rossi R, Ceciliani F, Giustarini D, Colombo R, Milzani A. Proteins as sensitive biomarkers of human conditions associated with oxidative stress. In: Dalle-Donne I, Scaloni A, Butterfeld DA, Eds. Redox Proteomics: From Protein Modifcations to Cellular Dysfunction and Diseases. Pp 487-525. Hoboken: John Wiley & Sons, 2006.
7. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 602-623.
8. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97: 1634-1658.
9. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401: 1-11.
10. Granot E, Kohen R. Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation. Am J Clin Nutr 2004; 79: 226-230.
11. Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med 2005; 26: 256-267.
12. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 2004; 19: 229-239.
13. Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Breda L, Rivella S, Cabantchik Zl. Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann NY Acad Sci 2005; 1054: 118-123.
14. Churg A. Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic Biol Med 2003; 34: 1230-1235.
15. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004; 61: 461-470.
16. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiologi-cal implications. J Physiol 2004; 555: 589-606.
17. Halliwell B. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 2006; 31: 509-515.
18. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 11: 431-433.
19. Yorek MA. Te role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 2003; 37: 471-480.
20. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006; 40: 183-192.
21. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212: 167-178.
22. Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet b cell. Free Radic Biol Med 2006; 41: 177-184.
23. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fuc-tuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
24. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH. Glucose fuctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008; 51: 183-190.
25. Stocker R, Keaney JF Jr. Role of oxidative modifcations in atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
26. Stocker R, Keaney JF Jr. New insights on oxidative stress in the artery wall. J Tromb Haemost 2005; 3: 1825-1834.
27. Nicholls SJ, Zheng L, Hazen SL. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 2005; 15: 212-219.
28. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1957; 2: 298-300.
29. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
30. Halliwell B, Gutteridge JMC. Ageing, nutrition, disease and therapy: a role for antioxidants? In: Halliwell B, Gutteridge JMC, Eds. Free radicals in Biology and Medicine, 3rd Ed. Pp 784-859. Oxford: Clarendon Press, 1999.
31. Masoro EJ. Caloric restriction and aging: an update. Exp Gerontol 2000; 35: 299-305.
32. Gruber J, Schafer S, Halliwell B. Te mitochondrial free radical theory of ageing-Where do we stand? Front Biosci 2008; 13: 6554-6579.
33. Masoro EJ. Caloric restriction-induced life extension of rats and mice: A critique of proposed mechanisms. Biochim Biophys Acta 2009 (in press).
34. Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996; 21: 641-649.
35. Jahoor F, Jackson A, Gazzard B, Philips G, Sharpstone D, Frazer ME, Heird W. Erythrocyte glutathione defciency in symptom-free HIV infection is associated with decreased synthesis rate. Am J Physiol 1999; 276: E205-E211.
36. Aukrust P, Muller F. Glutathione redox disturbances in human immunodefciency virus infection: immunologic and therapeutic consequences. Nutrition 1999; 15: 165-167.
37. Mahadik S P, Pillai A, Joshi S, Foster A. Prevention of oxida-tive stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry 2006; 18: 119-131.
38. Gupta S, Agarwal A, Sharma RK. Te role of placental oxi-dative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-816.
39. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 2004; 37: 1951-1962.
40. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Te infammatory response in mild and in severe psoriasis. Br J Dermatol 2004; 150: 917-928. (Pubitemid 38903524)
41. Gilgun-Sherki Y, Melamed E, Ofen D. Te role of oxida-tive stress in the pathogenesis of multiple sclerosis: the need for efective antioxidant therapy. J Neurol 2004; 251: 261-268.
42. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Metabolic biomarkers of increased oxida-tive stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80: 1611-1617.
43. Longoni B, Boschi E, Demontis GC, Ratto GM, Mosca F. Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels. FASEB J 2001; 15: 731-740.
44. Keys A. Mediterranean diet and public health: personal refections. Am J Clin Nutr 1995; 61(6 Suppl): 1321S-1323S.
45. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416.
46. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D, Willett WC. Te efect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001; 134: 1106-1114.
47. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. Fruit and vegetable juices and Alzheimer's disease: the Kame project. Am J Med 2006; 119: 751-759.
48. Bazzano LA, Li T Y, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 2008; 31: 1311-1317.
49. Margaill I, Plotkine M, Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 2005; 39: 429-443.
50. Rahman I, Kilty I. Antioxidant therapeutic targets in COPD. Curr Drug Targets 2006; 7: 707-720.
51. Eaton S. Te biochemical basis of antioxidant therapy in critical illness. Proc Nutr Soc 2006; 65: 242-249.
52. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361: 2017-2023
53. Miller ER 3d, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46.
54. Bleys J, Miller ER 3rd, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006; 84: 880-887.
55. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842-857.
56. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 2007; 335: 755.
57. Heart Protection Collaborative Study Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 "high-risk" individuals: a randomized placebo-controlled trial. Lancet 2002; 360:23-33.
58. Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002; 325: 11-14.
59. Tornwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Taylor PR, Albanes D, Huttunen JK. Efect of alpha-tocophe-rol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur Heart J 2004; 25: 1171-1178.
60. Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Tetu B, Harel F, Abdous B, Vigneault E, Vass S, Del Vecchio P, Roy J. Randomized trial of antioxidant vitamins to prevent acute adverse efects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005; 23: 5805-5813. (Pubitemid 46300177)
61. Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 2005; 294: 342-350.
62. Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A. Efects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005; 365: 1552-1560. (Pubitemid 40615404)
63. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 56-65. (Pubitemid 41002839)
64. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfeld J, Dagenais GR; HOPE and HOPE-TOO Trial Investigators. Efects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-1347.
65. Petersen RC, Tomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeifer E, Sano M, van Dyck CH, Tal LJ; Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-2388. (Pubitemid 40958434)
66. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA; Vascular Basis Study Group. Efect of intensive lipid lowering, with or without antioxi-dant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation 2005; 111: 1747-1755.
67. Kang JH, Cook N, Manson J, Buring JE, Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006; 166: 2462-2468.
68. Magliano D, McNeil J, Branley P, Shiel L, Demos L, Wolfe R, Kotsopoulos D, McGrath B. Te Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers. Eur J Cardiovasc Prev Rehabil 2006; 13: 341-347.
69. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; 367: 1145-1154.
70. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006; 354: 1796-1806.
71. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007; 167: 1610-1618.
72. Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insuf-fciency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 2008; 36: 81-86.
73. Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology 2008; 115: 822-829.
74. Te Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. Te efect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
75. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of efect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
76. Omenn GS, Goodman GE, Tornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Efects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155
77. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.
78. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154-160.
79. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-1592.
80. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004; 364: 1219-1228.
81. Te HOPE and HOPE-TOO Trial Investigators. Efects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-1347.
82. Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA. Efects of vitamin E on lipid peroxidation in healthy persons. JAMA 2001; 285(9): 1178-1182.
83. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
84. Roberts JM, Gammill HS. Pre-eclampsia: recent insights. Hypertension 2005; 46: 1243-1249.
85. Raijmakers MT, Peters WH, Steegers, EA, Poston L. Amino thiols, detoxifcation and oxidative stress in preeclampsia and other disorders of pregnancy. Curr Pharm Des 2005; 11: 711-734
86. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no 8. Arch Ophthalmol 2001, 119, 1417-1436.
87. Chew EY, Clemons T. Vitamin E and the Age-Related Eye Disease Study supplementation for age-related macular degeneration. Arch Ophthalmol 2005; 123: 395-396
88. Age-Related Eye Disease Study 2 (AREDS2). Bethesda, MD: National Eye Institute. [Accessed 2009 May 19]; Available from http://www.nei.nih.gov/areds2/ .
89. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45: 287-306.
90. Lotito SB, Frei B. Te increase in human plasma antioxidant capacity after apple consumption is due to the metabolic efect of fructose on urate, not apple-derived antioxidant favonoids. Free Radic Biol Med 2004; 37: 251-258.
91. Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002; 277: 30574-30580.
92. Sadik CD, Sies H, Schewe T. Inhibition of 15-lipoxygenases by favonoids: structure-activity relations and mode of action. Biochem Pharmacol 2003; 65: 773-781.
93. Halliwell B, Rafter J, Jenner A. Health promotion by favo-noids, tocopherols, tocotrienols, and other phenols: direct or indirect efects? Antioxidant or not? Am J Clin Nutr 2005; 81(1 Suppl): 268S-276S.
94. O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, Wiseman H. Consumption of favonoids in onions and black tea: lack of efect on F2-isoP and autoan-tibodies to oxidized LDL in healthy humans. Am J Clin Nutr 2001; 73: 1040-1044.
95. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 73: 326-340. (Pubitemid 44970442)
96. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 2008; 476: 107-112.
97. Natarajan L, Flatt SW, Sun X, Gamst AC, Major JM, Rock CL, Al-Delaimy W, Tomson CA, Newman VA, Pierce JP; Women's Healthy Eating and Living Study Group. Validity and systematic error in measuring carotenoid consumption with dietary self-report instruments. Am J Epidemiol 2006; 163: 770-778.
98. Caccetta RA, Croft KD, Beilin LJ, Puddey IB. Ingestion of red wine signifcantly increases plasma phenolic acid concentrations but does not acutely afect ex vivo lipoprotein oxi-dizability. Am J Clin Nutr 2000; 71: 67-74.
99. Halliwell B. Dietary polyphenols: good, bad, or indiferent for your health? Cardiovasc Res 2007; 73: 341-347.
100. Greenberg ER. Vitamin E supplements: good in theory, but is the theory good? Ann Intern Med 2005; 142: 75-76.
101. Frank E, Bendich A, Denniston M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr 2000; 72: 969-975.
102. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 2002; 162: 1472-1476.
103. Heinonen OP, Albanes D.Te efect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. Te Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029-1035.
104. Mino M. Use and safety of elevated dosages of vitamin E in infants and children. Int J Vitam Nutr Res Suppl 1989; 30: 69-80.
105. Tsai CL, Chang W T, Weng TI, Fang CC, Walson PD. A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ter 2005; 27: 336-341.
106. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev 1998; 3: 262-270.
107. Brigelius-Flohé R, Kluth D, Banning A. Is there a future for antioxidants in atherogenesis? Mol Nutr Food Res 2005; 49: 1083-1089.
108. Olmedo JM, Yiannias JA, Windgassen EB, Gornet MK. Scurvy: a disease almost forgotten. Int J Dermatol 2006; 45: 909-913.
109. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-1024.
110. Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant efects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int 2005; 67: 1371-1380.
111. Bailey DM, Raman S, McEneny J, Young IS, Parham KL, Hullin DA, Davies B, McKeeman G, McCord JM, Lewis MH. Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radic Biol Med 2006; 40: 591-600.
112. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 2008; 101: 14D-19D.
113. Blackhall ML, Fassett RG, Sharman JE, Geraghty DP, Coombes JS. Efects of antioxidant supplementation on blood cyclosporin A and glomerular fltration rate in renal transplant recipients. Nephrol Dial Transplant 2005; 20: 1970-1975
114. Sarkany RP.Erythropoietic protoporphyria (EPP) at 40. Where are we now? Photodermatol Photoimmunol Photomed 2002; 18: 147-152.
115. Hazell LJ, Stocker R. Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein. FEBS Lett 1997; 414: 541-544.
116. Sundquist AR, Brivida K, Sies H. Singlet oxygen quenching by carotenoids. Methods Enzymol 1994; 234: 384-388.
117. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007; 55: 207-216.
118. Niki E. Free radicals in the 1900's: from in vitro to in vivo. Free Radic Res 2000; 33: 693-704.
119. Frei B. To C or not to C, that is the question! J Am Coll Cardiol 2003; 42: 253-255.
120. Lee CY, Isaac HB, Wang H, Huang SH, Long LH, Jenner AM, Kelly RP, Halliwell B. Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant efects of dark soy sauce in humans. Biochem Biophys Res Commun 2006; 344: 906-911.
121. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8.
122. Bonnafous P, Vernhes M, Teissie J, Gabriel B. Te generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane. Biochim Biophys Acta 1999; 1461: 123-134.
123. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-623.
124. Adiga IK, Nair RR. A positive association between cardio-myocyte volume and serum malondialdehyde levels. Int J Cardiol 2007; 115: 246-248.
125. Agil A, Durán R, Barrero F, Morales B, Araúzo M, Alba F, Miranda MT, Prieto I, Ramírez M, Vives F.Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa. J Neurol Sci 2006; 240: 31-36.
126. Ahmed RS, Suke SG, Seth V, Jain A, Bhattacharya SN, Banerjee BD. Impact of oral vitamin E supplementation on oxidative stress & lipid peroxidation in patients with polymorphous light eruption. Indian J Med Res 2006; 123: 781-787.
127. Al-Saleh I, Billedo G, El-Doush I, El-Din Mohamed G, Yosef G. Selenium and vitamins status in Saudi children. Clin Chim Acta 2006; 368: 99-109.
128. Bednarek-Tupikowska G, Tworowska U, Jedrychowska I, Radomska B, Tupikowski K, Bidzinska-Speichert B, Milewicz A. Efects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in post-menopausal women. Clin Endocrinol 2006; 64: 463-468.
129. Block G, Dietrich M, Norkus E, Jensen C, Benowitz NL, Morrow JD, Hudes M, Packer L. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 2006; 17: 404-412.
130. Bloomer RJ, Goldfarb AH, McKenzie MJ. Oxidative stress response to aerobic exercise: comparison of antioxidant supplements. Med Sci Sports Exerc 2006; 38: 1098-1105.
131. Close GL, Ashton T, Cable T, Doran D, Holloway C, McArdle F, MacLaren DP. Ascorbic acid supplementation does not attenuate post-exercise muscle soreness following muscle-damaging exercise but may delay the recovery process. Br J Nutr 2006; 95: 976-981.
132. Ece A, Gürkan F, Kervancioglu M, Kocamaz H, Günes A, Atamer Y, Selek S. Oxidative stress, infammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 2006; 21: 545-552.
133. Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006; 40: 495-505.
134. Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung 2006; 184: 51-55.
135. Hsu W T, Tsai LY, Lin SK, Hsiao JK, Chen BH. Efects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus. Ann Clin Lab Sci 2006; 36: 174-178.
136. Huerta JM, Gonzalez S, Fernandez S, Patterson AM; Lasheras C. Lipid peroxidation, antioxidant status and survival in institutionalised elderly: a fve-year longitudinal study. Free Radic Res 2006; 40: 571-578.
137. Kalahasthi RB, Rao RHR, Murthy RBK. Plasma lipid per-oxidation and erythrocyte antioxidants status in workers exposed to nickel. Biomarkers 2006; 11: 241-249.
138. Kim YH, Kim CH, Cho MK, Kim KM, Lee SY, Ahn BW, Yang SY, Kim SM, Song TB. Total peroxyl radical-trapping ability and anti-oxidant vitamins of the umbilical venous plasma and the placenta in pre-eclampsia. J Obstet Gynaecol Res 2006; 32: 32-41.
139. Kocyigit A, Koylu AA, Keles H. Efects of pistachio nuts consumption on plasma lipid profle and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 2006; 16: 202-209.
140. Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res 2006; 37: 602-606.
141. Krediet TG, Kavelaars A, Vreman HJ, Heijnen CJ, van Bel F. Respiratory distress syndrome-associated infammation is. related to early but not late peri/intraventricular hemorrhage in preterm infants. J Pediatr 2006; 148: 740-746.
142. Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K. Lipid peroxidation & antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res 2005; 122: 529-534. (Pubitemid 43299931)
143. Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol 2006; 47: 117-122.
144. Misra R, Mangi S, Joshi S, Mittal S, Gupta SK, Pandey RM. LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled clinical trial. J Obstet Gynaecol Res 2006; 32: 299-304.
145. Morillas-Ruiz JM, Villegas Garcia JA, Lopez FJ, Vidal-Guevara ML, Zafrilla P. Efects of polyphenolic antioxidants on exercise-induced oxidative stress. Clin Nutr 2006; 25: 444-453.
146. Neri S, Signorelli S, Pulvirenti D, Mauceri B, Cilio D, Bordonaro F, Abate G, Interlandi D, Misseri M, Ignaccolo L, Savastano M, Azzolina R, Grillo C, Messina A, Serra A, Tsami A. Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus. Free Radic Res 2006; 40: 615-618.
147. Ozdogan M, Devay AO, Gurer A, Ersoy E, Devay SD, Kulacoglu H, Gundogdu H. Plasma total anti-oxidant capacity correlates inversely with the extent of acute appendicitis: a case control study. World J Emerg Surg 2006; 1: 6.
148. Pal BK, Kulkarni S, Bhandari Y, Ganesh BB, Goswami K, Reddy MV. Lymphatic flariasis: possible pathophysiological nexus with oxidative stress. Trans R Soc Trop Med Hyg 2006; 100: 650-655.
149. Sajewicz W, Milnerowicz S, Nabzdyk S. Blood plasma anti-oxidant defense in patients with pancreatitis. Pancreas 2006; 32: 139-144.
150. Schepens MA, Roelofs HM, Peters WH, Wanten GJ. No evidence for oxidative stress in patients on home parenteral nutrition. Clin Nutr 2006; 25: 939-948.
151. Steinberg JG, Delliaux S, Jammes Y. Reliability of diferent blood indices to explore the oxidative stress in response to maximal cycling and static exercises. Clin Physiol Funct Imaging 2006; 26: 106-112.
152. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006; 83: 1135-1141.
153. Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y, Kaftan HA, Kilic M. Cigarette smoking induced oxi-dative stress may impair endothelial function and coronary blood fow in angiographically normal coronary arteries. Circ J 2006; 70: 593-599.
154. Tauler P, Sureda A, Cases N, Aguiló A, Rodríguez-Marroyo JA, Villa G, Tur JA, Pons A. Increased lymphocyte antioxidant defences in response to exhaustive exercise do not prevent oxidative damage. J Nutr Biochem 2006; 17: 665-671.
155. Tzivras M, Koussoulas V, Giamarellos-Bourboulis EJ, Tzivras D, Tsaganos T, Koutoukas P, Giamarellou H, Archimandritis A. Role of soluble triggering receptor expressed on myeloid cells in infammatory bowel disease. World J Gastroenterol 2006; 12: 3416-3419. (Pubitemid 43933789)
156. Unfer TC, Conterato GM, da Silva JC, Duarte MM, Emanuelli T. Infuence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 2006; 369: 73-77.
157. White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC, Racine N, He Y, Yao G, Rouleau JL, Schifrin EL, Touyz RM. Increased systemic infammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci 2006; 110: 483-489.
158. Yardim-Akaydin S, Sepici A, Ozkan Y, Simsek B, Sepici V. Evaluation of allantoin levels as a new marker of oxida-tive stress in Behcet's disease. Scand J Rheumatol 2006; 35: 61-64.
159. Zwolinska D, Grzeszczak W, Szczepanska M, Kilis-Pstrusinska K, Szprynger K. Lipid peroxidation and antioxi-dant enzymes in children on maintenance dialysis. Pediatr Nephrol 2006; 21: 705-710.
160. Bamonti F, Novembrino C, Ippolito S, Soresi E, Ciani A, Lonati S, Scurati-Manzoni E, Cighetti G. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study. Clin Chem Lab Med 2006; 44: 391-395.
161. Christofdes J, Bridel M, Egerton M, Mackay GM, Forrest CM, Stoy N, Darlington LG, Stone TW. Blood 5-hydroxytryp-tamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J Neurochem 2006; 97: 1078-1088.
162. Attri S, Sharma N, Jahagirdar S, Tapa BR, Prasad R. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Pediatr Res 2006; 59: 593-597.
163. Baltacioglu E, Akalin FA, Alver A, Balaban F, Unsal M, Karabulut E. Total antioxidant capacity and superoxide dis-mutase activity levels in serum and gingival crevicular fuid in post-menopausal women with chronic periodontitis. J Clin Periodontol 2006; 33: 385-392.
164. Bogani P, Galli C, Villa M, Visioli F. Postprandial anti-in-fammatory and antioxidant efects of extra virgin olive oil. Atherosclerosis 2007; 190: 181-186.
165. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L, Stefanadis C. Te association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis 2007; 192: 169-176.
166. Mandrioli J, Del Rio D, Zini A, Nichelli P, Merelli E, Beltrami D, Cesari C, Pellegrini N, Brighenti F, Sola P. Total antioxidant capacity of cerebrospinal fuid is decreased in patients with motor neuron disease. Neurosci Lett 2006; 401: 203-208.
167. Melissas J, Malliaraki N, Papadakis JA, Tafampas P, Kampa M, Castanas E. Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obes Surg 2006; 16: 314-320.
168. Rabovsky A, Cuomo J, Eich N. Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin Chim Acta 2006; 371: 55-60.
169. Salvini S, Sera F, Caruso D, Giovannelli L, Visioli F, Saieva C, Masala G, Ceroti M, Giovacchini V, Pitozzi V, Galli C, Romani A, Mulinacci N, Bortolomeazzi R, Dolara P, Palli D. Daily consumption of a high-phenol extra-virgin olive oil reduces oxidative DNA damage in postmenopausal women. Br J Nutr 2006; 95: 742-751.
170. Schulpis KH, Papassotiriou I, Tsakiris S. 8-hydroxy-2-desox-yguanosine serum concentrations as a marker of DNA damage in patients with classical galactosaemia. Acta Paediatr 2006; 95: 164-169.
171. Tsakiris S, Parthimos T, Parthimos N, Tsakiris T, Schulpis KH. Te benefcial efect of L-cysteine supplementation on DNA oxidation induced by forced training. Pharmacol Res 2006; 53: 386-390.
172. Zitnanová I, Korytár P, Sobotová H, Horáková L, Sustrová M, Pueschel S, Duracková Z. Markers of oxidative stress in children with Down syndrome. Clin Chem Lab Med 2006; 44: 306-310.
173. Andersen LF, Jacobs DR Jr, Gross MD, Schreiner PJ, Dale Williams O, Lee DH. Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. Br J Nutr 2006; 95: 358-365.
174. Rousseau AS, Margaritis I, Arnaud J, Faure H, Roussel AM. Physical activity alters antioxidant status in exercising elderly subjects. J Nutr Biochem 2006; 17: 463-470.
175. Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population. Torax 2006; 61: 320-326.
176. Palan PR, Magneson AT, Castillo M, Dunne J, Mikhail MS. Efects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. Am J Obstet Gynecol 2006; 194: e35-e38.
177. Zhou JF, Xiao WQ, Zheng YC, Dong J, Zhang SM. Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis. Asian J Androl 2006; 8: 317-323.
178. Lee DH, Zacharski LR, Jacobs DR Jr. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. Am Heart J 2006; 151: 1247e1-1247e7.
179. Shoji H, Franke C, Campoy C, Rivero M, Demmelmair H, Koletzko B. Efect of docosahexaenoic acid and eicosapen-taenoic acid supplementation on oxidative stress levels during pregnancy. Free Radic Res 2006; 40: 379-384.
180. Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med 2006; 40: 689-697.
181. Pallardó F V, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, Castello G, Fernandez-Delgado R, Dunster C, Lloret A, Manini P, Pisanti MA, Vuttariello E, Pagano G. Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology 2006; 7: 211-220.
182. Rossi V, Leoncini S, Signorini C, Buonocore G, Pafetti P, Manganelli D, Ciccoli L, Comporti M. Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes. Free Radic Biol Med 2006; 40: 907-915.
183. Ahmadzadehfar H, Oguogho A, Efthimiou Y, Kritz H, Sinzinger H. Passive cigarette smoking increases isopros-tane formation. Life Sci 2006; 78: 894-897.
184. Cottone S, Palermo A, Vaccaro F, Raspanti F, Buscemi B, Incalcaterra F, Cerasola G. In renal transplanted patients infammation and oxidative stress are interrelated. Transplant Proc 2006; 38: 1026-1030.
185. Cottone S, Mulè G, Nardi E, Vadalà A, Guarneri M, Briolotta C, Arsena R, Palermo A, Riccobene R, Cerasola G. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens 2006; 19: 313-318.
186. Elesber AA, Best PJ, Lennon RJ, Mathew V, Rihal CS, Lerman LO, Lerman A. Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res 2006; 40: 385-391.
187. Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P. Systemic infammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006; 44: 1167-1174.
188. Kato I, Ren J, Heilbrun LK, Djuric Z. Intra-and inter-individual variability in measurements of biomarkers for oxi-dative damage in vivo: Nutrition and Breast Health Study. Biomarkers 2006; 11: 143-152.
189. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D. High redox thiore-doxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 2006; 367: 156-161.
190. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M. Oxidation and carboxy methyl lysine-modifcation of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 2005; 28: 973-980.
191. Trombetta D, Gangemi S, Saija A, Minciullo PL, Cimino F, Cristani M, Briuglia S, Piraino B, Isola S, Salpietro CD. Increased protein carbonyl groups in the serum of patients afected by thalassemia major. Ann Hematol 2006; 85: 520-522.
192. Zurawa-Janicka D, Renke J, Popadiuk S, Skorko-Glonek J, Szumera M, Plata-Nazar K, Ulko P, Wozniak M, Lipinska B. Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis. Scand J Rheumatol 2006; 35: 193-200.
193. Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 858-864.
194. Pawlak K, Pawlak D, Mysliwiec M. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. Med Sci Monit 2006; 12: CR181-CR185.
195. Mylona-Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. Pediatr Diabetes 2006; 7: 51-59.
196. Wurzinger S, Bratu M, Wonisch W, Wintersteiger R, Halwachs-Baumann G, Porta S. Interdependency of the oxi-dizability of lipoproteins and peroxidase activity with base excess, HCO3, pH and magnesium in human venous and capillary blood. Life Sci 2006; 78: 1754-1759.
197. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Harrison DG, Quyyumi AA. Te relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006; 47: 1005-1011.
198. Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol 2006; 76: 230-236.
199. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isofavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 2006; 83: 1118-1125.
200. Awadallah SM, Hamad M, Jbarah I, Salem NM, Mubarak MS. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease. Clin Chim Acta 2006; 365: 330-336.
201. Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J 2006; 36: 237-243.
202. Sasaki M. Development of vitamin E-modifed polysulfone membrane dialyzers. J Artif Organs 2006; 9: 50-60.
203. Odetti P, Traverso N, Monacelli F, Menini S, Vazzana J, Tasso B, Pronzato MA, Robaudo C, Deferrari G. Vitamin E-coated flter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions. Free Radic Res 2006; 40: 207-212.
204. Sureda A, Batle JM, Tauler P, Ferrer MD, Tur JA, Pons A. Vitamin C supplementation infuences the antioxidant response and nitric oxide handling of erythrocytes and lymphocytes to diving apnea. Eur J Clin Nutr 2006; 60: 838-846.
205. Khan F, Siddiqui AA. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fuid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin Chim Acta 2006; 370: 100-107.
206. Ohashi S, Nishio A, Nakamura H, Kido M, Kiriya K, Asada M, Tamaki H, Fukui T, Kawasaki K, Watanabe N, Yodoi J, Okazaki K, Chiba T. Clinical signifcance of serum thiore-doxin 1 levels in patients with acute pancreatitis. Pancreas 2006; 32: 264-270.
207. Arguelles S, Machado MJ, Ayala A, Machado A, Hervias B. Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birth. Free Radic Res 2006; 40: 565-570.
208. Fialova L, Malbohan I, Kalousova M, Soukupova J, Krofta L, Stipek S, Zima T. Oxidative stress and infammation in pregnancy. Scand J Clin Lab Invest 2006; 66: 121-127.
209. Massaccesi L, Corsi MM, Baquero-Herrera CJ, Licastro F, Tringali C, Venerando B, Lombardo A, Alberghino A, Goi G. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing? Mech Ageing Dev 2006; 127: 324-331.
210. Nayak C, Nayak D, Raja A, Rao A. Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients. Clin Chem Lab Med 2006; 44: 460-463.
211. Rossi R, Dalle-Donne I, Milzani A, Giustarini D. Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clin Chem 2006; 52: 1406-1414.
212. Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, Morooka T, Imoto Y, Takeda Y, Sendo F, Node K. Stent-induced neu-trophil activation is associated with an oxidative burst in the infammatory process, leading to neointimal thickening. Tromb Haemost 2006; 95: 43-48.
213. Aydin A, Arsova-Sarafnovska Z, Sayal A, Eken A, Erdem O, Erten K, Ozgök Y, Dimovski A. Oxidative stress and antioxi-dant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 2006; 39: 176-179.
214. Chandrasena LG, Chackrewarthy S, Perera PT, de Silva D. Erythrocyte antioxidant enzymes in patients with cataract. Ann Clin Lab Sci 2006; 36: 201-204.
215. Nikolic-Kokic A, Stevic Z, Blagojevic D, Davidovic B, Jones DR, Spasic MB. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med 2006; 44: 589-593.
216. Amer J, Ghoti H, Rachmilewitz E, Koren A, Levin C, Fibach E. Red blood cells, platelets and polymorphonuclear neu-trophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2006; 132: 108-113.
217. Bravi MC, Armiento A, Laurenti O, Cassone-Faldetta M, De Luca O, Moretti A, De Mattia G. Insulin decreases intracellu-lar oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2006; 55: 691-695.
218. Stepniewska J, Dolegowska B, Ciechanowski K, Kwiatkowska E, Millo B, Chlubek D. Erythrocyte antioxidant. defense system in patients with chronic renal failure according to the hemodialysis conditions. Arch Med Res 2006; 37: 353-359.
219. Biesiada G, Krzemien J, Czepiel J, Teległów A, Dabrowski Z, Spodaryk K, Mach T.Rheological properties of erythrocytes in patients sufering from erysipelas. Examination with LORCA device. Clin Hemorheol Microcirc 2006; 34: 383-390.
220. Saeki T, Ichiba M, Tanabe N, Ueki M, Okamoto K, Matsunaga Y, Hosho K, Kanbe T, Tsuchiya H, Kurimasa A, Yamada S, Hirooka Y, Hisatome I, Kishimoto Y, Suou T, Murawaki Y, Kawasaki H, Yodoi J, Shiota G. Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis. Liver Int 2006; 26: 157-165.
221. Abu-Amero KK, Bosley TM. Increased relative mitochon-drial DNA content in leucocytes of patients with NAION. Br J Ophthalmol 2006; 90: 823-825.
222. Aizawa H, Makita Y, Sumitomo K, Aburakawa Y, Katayama T, Nakatani-Enomoto S, Suzuki Y, Fujiwara K, Enomoto H, Kuroda K, Kimura T, Yahara O, Koyama S, Maruyama J, Nakamura M, Hasebe N, Kikuchi K. Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack. Intern Med 2006; 45: 1-4.
223. Wong CH, Liu TZ, Chye SM, Lu FJ, Liu YC, Lin ZC, Chen CH. Sevofurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils. Food Chem Toxicol 2006; 44: 1399-1407.
224. Alidoost F, Gharagozloo M, Bagherpour B, Jafarian A, Sajjadi SE, Hourfar H, Moayedi B. Efects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients. Int Immunopharmacol 2006; 6: 1305-1310.
225. Prigione A, Begni B, Galbussera A, Beretta S, Brighina L, Garofalo R, Andreoni S, Piolti R, Ferrarese C. Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage. Neurobiol Dis 2006; 23: 36-43.
226. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006; 29: 283-289.
227. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stufer RG, Tedesco M, Maccarrone M. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int 2006; 69: 1450-1454.
228. Zana M, Szécsényi A, Czibula A, Bjelik A, Juhász A, Rimanóczy A, Szabó K, Vetró A, Szucs P, Várkonyi A, Pákáski M, Boda K, Raskó I, Janka Z, Kálmán J. Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes. Biochem Biophys Res Commun 2006; 345: 726-733.
229. Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ. Modifcation of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr 2006; 83: 163-169.
230. Grifths HR, Møller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Mol Aspects Med 2002; 23: 101-208.
231. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-255.
232. Schwedhelm E, Benndorf RA, Böger RH, Tsikas D. Mass spectrometric analysis of F-isoP: markers and mediators in human disease. Curr Pharmac Anal 2007; 3: 39-51.
233. Ryberg H, Caidahl K. Chromatographic and mass spectrometric methods for quantitative determination of 3-nitroty-rosine in biological samples and their application to human samples. J Chromatogr B 2007; 851: 160-171.
234. Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, BeilinLJ, Puddey IB. Measurement of urinary F2-isoP as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999; 272: 209-215.
235. Devaraj S, Hirany SV, Burk RF, Jialal I.Divergence between LDL oxidative susceptibility and urinary F2-isoP as measures of oxidative stress in type 2 diabetes. Clin Chem 2001; 47: 1974-1979.
236. Vassalle C, Andreassi MG. Circulation 2004; 109: e49.
237. In reply: Schwedhelm E, Maas R, Böger R, Brümmer J, Berger J, Barting A, Lenzen H, Tsikas D, Gutzki FM, Frölich JC. Circulation 2004; 109: e50.
238. Tsikas D, Schwedhelm E, Suchy MT, Niemann J, Gutzki FM, Erpenbeck VJ, Hohlfeld JM, Surdacki A, Frölich JC. Divergence in urinary 8-iso-PGF2ot (iPF2ot-III, 15-F2t-IsoP) levels from GC-tandem MS quantifcation after thin-layer chromatography and immunoafnity column chromatography reveals heterogeneity of 8-iso-PGF2ot. Possible methodological, mechanistic and clinical implications. J Chromatogr B 2003; 794: 237-255.
239. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2ot: an idex for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins, Leulotrienes Essential Fatty Acids 1998; 58: 319-325.
240. Rossi R, Milzani A, Dalle-Donne I, Giustarini D, Lusini L, Colombo R, Di Simplicio P. Blood glutathione disulfde: in vivo factor or in vitro artifact? Clin Chem 2002; 48: 742-753.
241. Collins AR, Cadet J, Moller L, Poulsen HE, Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch Biochem Biophys 2004; 423: 57-65.
242. Tsikas D, Caidahl K. Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma. J Chromatogr B 2005; 814: 1-9.
243. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical method validation-a revisit with a decade of progress. Pharm Res 2000; 17: 1551-1557.
244. Ermer J.Validation in pharmaceutica analysis. Part 1: An integrated approach. J Pharm Biomed Analysis 2001; 24: 755-767.
245. Mas E, Michel F, Guy A, Bultel V, Falquet Y, Chardon P, Rossi JC, Cristol JP, Durand T. Quantifcation of urinary F-isoP with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry: application to polytraumatized patients. J Chromatogr B 2008; 872: 133-140.
246. Chirico S, Smith C, Marchant C, Mitchinson MJ, Halliwell B.Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Res Commun 1993; 19: 51-57.
247. Dadgar D, Burnett PE, Choc MG, Gallicano K, Hooper JW. Application issues in bioanalytical method validation, sample analysis and data reporting. J Pharm Biomed Anal 1995; 13: 89-97.
248. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glu-tathione: implication in redox and detoxifcation. Clin Chim Acta 2003; 333: 19-39.
249. Capitan P, Malmezat T, Bruille D, Obled C. Gas chro-matographic-mass spectrometric analysis of stable isotopes of cysteine and glutathione in biological samples. J Chromatogr B 1999; 732: 127-135.
250. Duncan MW. A review of approaches to the analysis of 3-ni-trotyrosine. Amino Acids 2003; 25: 351-361.
251. Gaut JP, Byun, J, Tran HD, Heinecke JW. Artifact-free quan-tifcation of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spec-trometry and liquid chromatography-electrospray ioniza-tion tandem mass spectrometry. Anal Biochem 2002; 300: 252-259. (Pubitemid 34093701)
252. Frost MT, Halliwell B, Moore KP. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chroma-tography/mass spectrometry method that avoids nitration artifacts. Biochem J 2000; 345: 453-458.
253. Tsikas D, Schwedhelm E, Stutzer FK, Gutzki FM, Rode I, Mehls C, Frolich JC. Accurate quantifcation of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J Chromatogr B 2003; 784: 77-90.
254. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993; 57(5 Suppl): 779S-785S.
255. Pompella A, Maellaro E, Casini A F, Ferrali M, Ciccoli L, Comporti M. Measurement of lipid peroxidation in vivo: a comparison of diferent procedures. Lipids 1987; 22: 206-211.
256. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and signifcance. Am J Clin Nutr 1993; 57 (5 Suppl): 715S-725S.
257. Wilson R, Lyall K, Smyth L, Fernie CE, Riemersma RA. Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of 'oxidative stress' in vivo. Free Radic Biol Med 2002; 32: 162-168.
258. Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. F2-isoP are not just markers of oxidative stress. Free Radic Biol Med 2008; 44: 247-256.
259. Jahn U, Galano JM, Durand T. Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angew Chem Int Ed 2008; 47: 5894-5955.
260. Davies SS. Lipidotac approaches to measuring isoprotanes and other markers of oxidative stress. Eur J Lipid Sci Technol 2009; 111: 64-74.
261. Milne GL, Yin H, Brooks JD, Sanchez S, Jackson Roberts L 2nd, Morrow JD. Quantifcation of F2-isoP in biological fuids and tissues as a measure of oxidant stress. Methods Enzymol 2007; 433: 113-126.
262. Basu S. F2-isoP in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008; 10: 1405-1434.
263. Morrow JD. Quantifcation of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Tromb Vasc Biol 2005; 25: 279-286.
264. Schwedhelm E, Boger RH. Application of gas chromatogra-phy-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin Chem Lab Med 2003; 41: 1552-1561.
265. Gopaul NK, Zacharowski K, Halliwell B, Anggard EE. Evaluation of the postprandial efects of a fast-food meal on human plasma F(2)-isoprostane levels. Free Radic Biol Med 2000; 28: 806-814.
266. Zhao K, Whiteman M, Spencer JP, Halliwell B. DNA damage by nitrite and peroxynitrite: protection by dietary phenols. Methods Enzymol 2001; 335: 296-307.
267. Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr 2000; 72: 1082-1087.
268. Halliwell B. Efect of diet on cancer development: is oxida-tive DNA damage a biomarker? Free Radic Biol Med 2002; 32: 968-974.
269. Prior RL, Cao G. In vivo total antioxidant capacity: comparison of diferent analytical methods. Free Radic Biol Med 1999; 27: 1173-1181.
270. Huang D, Ou B, Prior RL. Te chemistry behind antioxidant capacity assays. J Agric Food Chem 2005; 53: 1841-1856.
271. Ghiselli A, Serafni M, Natella F, Scaccini C. Total antioxi-dant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000; 29: 1106-1114.
272. Benzie IF, Strain JJ. Te ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239: 70-76.
273. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr 2007; 137: 1493-1495.
274. Kadiiska MB, Gladen BC, Baird DD, Dikalova AE, Sohal RS, Hatch GE, Jones DP, Mason RP, Barrett JC. Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? Free Radic Biol Med 2000; 28: 838-845.
275. MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999; 32: 263-268.
276. Serafni M, Bugianesi R, Maiani G, Valtuena S, De Santis S, Crozier A. Plasma antioxidants from chocolate. Nature 2003; 424: 1013.
277. Flammer AJ, Hermann F, Sudano I, Spieker L, Hermann M, Cooper KA, Serafni M, Luscher TF, Ruschitzka F, Noll G, Corti R. Dark chocolate improves coronary vasomo-tion and reduces platelet reactivity. Circulation 2007; 116: 2376-2382.
278. Halliwell B. Plasma antioxidants: health benefts of eating chocolate? Nature 2003; 426: 787.
279. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R. Age-related infuence on thiol, disulfde, and protein-mixed disulfde levels in human plasma. J Gerontol A Biol Sci Med Sci 2006; 61: 1030-1038.
280. Förstermann U. Endothelial No synthase as a source of NO and superoxide. Eur J Clin Pharmacol 2006; 62: 5-12.
281. Giustarini D, Milzani A, Colombo R, Dalle-Donne I, Rossi R. Nitric oxide and S-nitrosothiols in human blood. Clin Chim Acta 2003; 330: 85-98.
282. Tsikas D, Hohlfeld HM. On the importance of the use of proper approaches for comparison of analytical methods for serum nitrate and for evaluation of reference concentrations. Clin Biochem 2009; 42: 1200-1201.
283. Tsikas D. Analysis of nitrite and nitrate in biological fuids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J Chromatogr B 2007; 851: 51-70.
284. Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol 2008; 440: 361-380.
285. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, Kelm M. Plasma nitrite rather than nitrate refects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 2001; 98: 12814-12819.
286. Yang BK, Vivas EX, Reiter CD, Gladwin MT. Methodologies for the sensitive and specifc measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 2003; 37: 1-10.
287. MacArthur PH, Shiva S, Gladwin MT. Measurement of circulating nitrite and S-nitrosothiols by reductive chemilumi-nescence. J Chromatogr B 2007; 851: 93-105.
288. Sureda A, Tauler P, Aguilo A, Fuentespina E, Cordova A, Tur JA, Pons A. Blood cell NO synthesis in response to exercise. Nitric Oxide 2006; 15: 5-12.
289. Giustarini D, Dalle-Donne I, Colombo R, Milzani A, Rossi R. Adaptation of the Griess reaction for detection of nitrite in human plasma. Free Radic Res 2004; 38: 1235-1240.
290. Giustarini D, Milzani A, Colombo R, Dalle-Donne I, Rossi R. Nitric oxide, S-nitrosothiols and hemoglobin: is methodology the key? Trends Pharmacol Sci 2004; 25: 311-316.
291. Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature 2005; 435: 737-738.
292. Normile D, Vogel G, Couzin J. Cloning. South Korean team's remaining human stem cell claim demolished. Science 2006; 311: 156-157.
293. Sudbo J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimaki A, Sudbo A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. Non-steroidal anti-infammatory drugs and the risk of oral cancer: a nested case-control study. Lancet 2005; 366: 1359-1366.
294. Horton R. Expression of concern: non-steroidal anti-infam-matory drugs and the risk of oral cancer. Lancet 2006; 367: 196 (Pubitemid 43107654)
295. European Standards Committee on Oxidative DNA Damage (ESCODD). Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radic Biol Med 2003; 34: 1089-1099.
296. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Tiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC.Biomarkers of Oxidative Stress Study II. Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005; 38: 698-710.
297. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, Fitzgerald GA, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sun J, Walter PB, Tomer KB, Barrett JC, Mason RP.Biomarkers of Oxidative Stress Study III. Efects of the nonsteroidal anti-infammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 2005; 38: 711-718.
298. Altman DG. Poor-quality medical research: what can journals do? JAMA 2002; 287: 2765-2767.
299. Stichtenoth DO, Marhauer V, Tsikas D, Gutzki FM, Frölich JC. Efects of specifc COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney Int 2005; 68: 2197-2207.